X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1519) 1519
Book Review (429) 429
Book / eBook (247) 247
Publication (140) 140
Newspaper Article (17) 17
Conference Proceeding (11) 11
Book Chapter (9) 9
Magazine Article (7) 7
Dissertation (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1391) 1391
index medicus (1368) 1368
male (841) 841
female (807) 807
urogenital system (650) 650
oncology (473) 473
middle aged (444) 444
cancer (443) 443
aged (406) 406
adult (334) 334
urogenital neoplasms - drug therapy (307) 307
animals (250) 250
chemotherapy (204) 204
tumors (194) 194
urology (192) 192
care and treatment (190) 190
diseases (189) 189
abridged index medicus (180) 180
prostate cancer (177) 177
surgery (173) 173
medicine (172) 172
urology & nephrology (171) 171
treatment outcome (161) 161
radiotherapy (157) 157
therapy (157) 157
antineoplastic agents - therapeutic use (156) 156
aged, 80 and over (150) 150
research (138) 138
child (137) 137
medicine & public health (136) 136
genitourinary organs (135) 135
diagnosis (132) 132
prognosis (130) 130
patients (129) 129
risk factors (128) 128
prostatic neoplasms - drug therapy (127) 127
health aspects (125) 125
radiology, nuclear medicine & medical imaging (124) 124
urologic diseases (123) 123
urologic and male genital diseases (121) 121
neoplasms (119) 119
urogenital neoplasms - therapy (119) 119
antineoplastic combined chemotherapy protocols - therapeutic use (116) 116
hematology, oncology and palliative medicine (115) 115
article (114) 114
retrospective studies (114) 114
urogenital neoplasms - pathology (111) 111
mice (107) 107
adolescent (105) 105
bladder (101) 101
metastasis (101) 101
radiology (101) 101
carcinoma (100) 100
cell line, tumor (100) 100
prostate (99) 99
analysis (93) 93
bladder cancer (91) 91
urogenital neoplasms (91) 91
drug therapy (90) 90
urinary bladder neoplasms - drug therapy (90) 90
cancer therapies (86) 86
studies (84) 84
expression (83) 83
prostatic neoplasms - pathology (83) 83
child, preschool (82) 82
research article (81) 81
male urogenital diseases (78) 78
prostatic neoplasms - radiotherapy (78) 78
breast neoplasms - drug therapy (75) 75
infant (75) 75
toxicity (75) 75
radiology and nuclear medicine (74) 74
female genital diseases and pregnancy complications (73) 73
neoplasm staging (73) 73
pathology (73) 73
follow-up studies (72) 72
urinary tract (72) 72
breast cancer (71) 71
female urogenital diseases (69) 69
apoptosis (67) 67
combined modality therapy (67) 67
urinary organs (67) 67
survival (66) 66
urogenital neoplasms - diagnosis (66) 66
urogenital system - radiation effects (66) 66
antineoplastic agents - adverse effects (65) 65
gene expression (65) 65
neoplasms - drug therapy (65) 65
proteins (65) 65
bladder-cancer (64) 64
radiotherapy dosage (64) 64
quality of life (63) 63
development and progression (62) 62
time factors (62) 62
medical prognosis (61) 61
antineoplastic agents - administration & dosage (59) 59
breast-cancer (59) 59
cisplatin - administration & dosage (59) 59
cell biology (58) 58
cisplatin (58) 58
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (198) 198
Scarborough Hospital - General (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Lakeridge Health Sciences - Oshawa (6) 6
St. Michael's Hospital - Stacks (6) 6
Toronto East General Hospital - Stacks (5) 5
Humber River Regional Hospital - Finch Stacks (4) 4
Online Resources - Online (4) 4
Scarborough Hospital - Birchmount (4) 4
Holland Bloorview Kids Rehabilitation - Stacks (3) 3
Trillium Health Centre - Stacks (3) 3
Credit Valley Hospital - Reference (2) 2
Credit Valley Hospital - Stacks (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Providence Healthcare - Reference (2) 2
Providence Healthcare - Stacks (2) 2
St Josephs Health Centre - Stacks (2) 2
Women's College Hospital - Stacks (2) 2
Gerstein Science - Not Returned (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Markham Stouffville Hospital - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Reserve desk (1) 1
Scarborough Hospital - Hospital Department (1) 1
Toronto East General Hospital - Online (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1622) 1622
German (57) 57
Japanese (56) 56
French (26) 26
Italian (13) 13
Spanish (10) 10
Polish (7) 7
Russian (7) 7
Arabic (1) 1
Chinese (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Norwegian (1) 1
Romanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, pp. e0130142 - e0130142
Background The potential predictive role of programmed death-ligand-1 (PD-L1) expression on tumor cells in the context of solid tumor treated with checkpoint... 
CTLA-4 BLOCKADE | ANTI-PD-L1 ANTIBODY | EFFICACY | SAFETY | MULTIDISCIPLINARY SCIENCES | OPEN-LABEL | ANTITUMOR IMMUNITY | CLINICAL ACTIVITY | IPILIMUMAB | CHEMOTHERAPY | CHECKPOINT BLOCKADE | Lung Neoplasms - drug therapy | Melanoma - diagnosis | Prognosis | Humans | Gene Expression Regulation, Neoplastic | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Neoplasms - diagnosis | Urogenital System - pathology | Neoplasms - genetics | Melanoma - genetics | Urogenital Neoplasms - drug therapy | Lung - metabolism | Lung Neoplasms - genetics | Lung - pathology | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | Treatment Outcome | Urogenital System - drug effects | B7-H1 Antigen - genetics | Neoplasms - drug therapy | Urogenital System - metabolism | Urogenital Neoplasms - genetics | Lung - drug effects | Melanoma - drug therapy | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - diagnosis | Urogenital Neoplasms - diagnosis | Lung cancer, Non-small cell | Care and treatment | Tumors | PD-1 protein | Lung cancer | Clinical trials | Antibodies | Oncology | Cancer therapies | Confidence intervals | Immunotherapy | Sensitivity analysis | Tumor cells | Melanoma | Non-small cell lung carcinoma | Patients | Pathology | Immune checkpoint | Medical prognosis | PD-L1 protein | Response rates | Biomarkers | Ligands | Mutation | Solid tumors | Blood diseases | Cancer | Apoptosis | Index Medicus
Journal Article
International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 06/2012, Volume 83, Issue 2, pp. 720 - 726
Purpose: To analyze the effect of reduced-dose radiotherapy on local control in children with low-risk rhabdomyosarcoma (RMS) treated in the Children's... 
Radiotherapy | Local control | Low risk | Rhabdomyosarcoma | PARAMENINGEAL RHABDOMYOSARCOMA | INTERNATIONAL SOCIETY | INTERGROUP-RHABDOMYOSARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | SURGICAL-MANAGEMENT | FAILURE | RADIATION-THERAPY | STUDY-IV | GROUP-III PATIENTS | ONCOLOGY | PATIENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lymph Node Excision | Prostatic Neoplasms - radiotherapy | Age Factors | Humans | Child, Preschool | Infant | Male | Rhabdomyosarcoma, Embryonal - surgery | Neoplasm, Residual | Young Adult | Rhabdomyosarcoma, Embryonal - secondary | Treatment Failure | Adult | Female | Urogenital Neoplasms - drug therapy | Orbital Neoplasms - surgery | Child | Infant, Newborn | Orbital Neoplasms - radiotherapy | Prostatic Neoplasms - drug therapy | Rhabdomyosarcoma, Embryonal - pathology | Quality Control | Prostatic Neoplasms - pathology | Drug Administration Schedule | Prostatic Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Orbital Neoplasms - pathology | Urogenital Neoplasms - pathology | Orbital Neoplasms - drug therapy | Lymphatic Metastasis | Rhabdomyosarcoma, Embryonal - drug therapy | Tumor Burden | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Radiotherapy Dosage - standards | Urogenital Neoplasms - radiotherapy | Adolescent | Combined Modality Therapy - methods | Urogenital Neoplasms - surgery | Rhabdomyosarcoma, Embryonal - radiotherapy | Second-Look Surgery | Head and Neck Neoplasms - surgery | Index Medicus | SURGERY | PATIENTS | NEOPLASMS | LYMPH NODES | FAILURES | RADIOLOGY AND NUCLEAR MEDICINE | ENDOXAN | RADIATION DOSES | RADIOTHERAPY | CHILDREN | CONTROL | HAZARDS
Journal Article
The Lancet, ISSN 0140-6736, 12/2018, Volume 392, Issue 10162, pp. 2353 - 2366
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2016, Volume 27, Issue 5, pp. 868 - 874
Journal Article
1983, ISBN 9783540121633, Volume 85., 151
Book
1975, American lecture series, publication no. 972. A monograph in the Bannerstone division of American lectures in living chemistry, ISBN 9780398033194, xiii, 268
Book
Clinical Cancer Research, ISSN 1078-0432, 05/2010, Volume 16, Issue 10, pp. 2861 - 2871
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2017, Volume 98, Issue 2, pp. 286 - 295
Purpose To report the genitourinary (GU) and gastrointestinal (GI) morbidity and erectile dysfunction in a randomized trial comparing 2 methods of dose... 
Radiology | Hematology, Oncology and Palliative Medicine | CONFORMAL RADIATION-THERAPY | ONCOLOGY | CLINICALLY LOCALIZED ADENOCARCINOMA | INTENSITY-MODULATED RADIOTHERAPY | TOXICITY | EXPERIENCE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prostatic Neoplasms - radiotherapy | Fecal Incontinence - epidemiology | Follow-Up Studies | Humans | Middle Aged | Urogenital System - radiation effects | Diarrhea - epidemiology | Male | Erectile Dysfunction - epidemiology | Pelvis | Gastrointestinal Hemorrhage - epidemiology | Feasibility Studies | Incidence | Time Factors | Aged, 80 and over | Gonadotropin-Releasing Hormone - therapeutic use | Fecal Incontinence - etiology | Prostatic Neoplasms - drug therapy | Radiotherapy Dosage | Re-Irradiation - adverse effects | Brachytherapy - methods | Gonadotropin-Releasing Hormone - adverse effects | Logistic Models | Rectum - radiation effects | Combined Modality Therapy - adverse effects | Erectile Dysfunction - etiology | Urinary Incontinence - etiology | Re-Irradiation - methods | Disease-Free Survival | Gastrointestinal Hemorrhage - etiology | Urination Disorders - epidemiology | Urination Disorders - etiology | Intention to Treat Analysis | Androgen Antagonists - therapeutic use | Diarrhea - etiology | Radiotherapy, Conformal - adverse effects | Urinary Incontinence - epidemiology | Aged | Combined Modality Therapy - methods | Androgen Antagonists - adverse effects | Brachytherapy - adverse effects | Radioisotope brachytherapy | Impotence | Clinical trials | Health aspects | Prostate cancer | Risk factors | Morbidity | Prevalence studies (Epidemiology) | Index Medicus | PROSTATE | DISEASE INCIDENCE | EXTERNAL BEAM RADIATION THERAPY | NEOPLASMS | RADIATION HAZARDS | MEN | RADIOLOGY AND NUCLEAR MEDICINE | BRACHYTHERAPY | GY RANGE 10-100
Journal Article
Journal Article